mycophenol mofetil (MMF, Cellcept®) 500 mg BID

DRUG2 trials

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

AtherosclerosisHIV Infection

Phase 4

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)HIV Infection

Start: 2005-04-30Target: 90Updated: 2009-07-22

Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Atherosclerosis, HIV Infection

Start: 2005-04-30Target: 90Updated: 2009-07-22